Exor N.V. holds a concentrated book of 3 stocks worth $5.4B as of Q1 2026 (disclosed May 13, 2026, a ~45-day 13F lag). Their largest long position is KONINKLIJKE PHILIPS N V at 93% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1589122/holdings"
Use Arkolith to show Exor N.V.'s latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
0% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Other tracked managers holding the same core names as Exor N.V.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 2 / 3 | $63.6M |
| VANGUARD GROUP INC | 2 / 3 | $58.8M |
| Ken Griffin | 2 / 3 | $53.2M |
| UBS Group AG | 2 / 3 | $25.9M |
| STATE STREET CORP | 2 / 3 | $22.1M |
| MORGAN STANLEY | 2 / 3 | $21.3M |
| GEODE CAPITAL MANAGEMENT, LLC | 2 / 3 | $21.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2 / 3 | $20.8M |
Ranked by how many of Exor N.V.'s top 3 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Koninklijke Philips N V NY REGIS SHS NEW | $5.0B | 182.54M | 92.9% | —Held | |
| 2 | Via Transn Inc COM CL A | $211.8M | 14.12M | 3.9% | —Held | |
| 3 | Clarivate PLC ORD SHS | $170.3M | 67.29M | 3.2% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 13, 2026 | 3 | $5.4B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 3, 2026 | 3 | $5.6B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 | 3 | $5.9B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 16, 2025 | 2 | $4.7B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 | 2 | $4.7B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 22, 2025 | 2 | $4.5B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 17, 2024 | 2 | $5.9B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 9, 2024 | 2 | $4.5B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 16, 2024 | 2 | $3.3B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 12, 2024 | 2 | $3.9B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 | 2 | $3.0B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 2 | $905.4M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 1 | $304.9M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 1 | $139.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.